Green Tea Polyphenols Inhibit Colorectal Tumorigenesis in Azoxymethane-Treated F344 Rats

References

• Siegel RL, Miller KD, and Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65, 5–29, 2015. doi: 10.3322/caac.21254
   PubMed Web of Science ®Google Scholar
• Center MM, Jemal A, Smith RA, and Ward E: Worldwide variations in colorectal cancer. CA Cancer J Clin 59, 366–378, 2009.
   PubMed Web of Science ®Google Scholar
• Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, et al.: Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 10, 53–58, 2001.
   PubMed Web of Science ®Google Scholar
• Yang CS, and Hong J: Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr 33, 161–181, 2013.
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang X, Lu G, and Picinich SC: Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9, 429–439, 2009.
   PubMed Web of Science ®Google Scholar
• Suganuma M, Ohkura Y, Okabe S, and Fujiki H: Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J Cancer Res Clin Oncol 127, 69–72, 2001.
   PubMed Web of Science ®Google Scholar
• Ju J, Hong J, Zhou JN, Pan Z, Bose M, et al.: Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 65, 10623–10631, 2005.
   PubMed Web of Science ®Google Scholar
• Hao X, Sun Y, Yang CS, Bose M, Lambert JD, et al.: Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins. Nutr Cancer 59, 62–69, 2007.
   PubMed Web of Science ®Google Scholar
• Orner GA, Dashwood WM, Blum CA, Diaz GD, Li Q, et al.: Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 24, 263–267, 2003.
   PubMed Web of Science ®Google Scholar
• Yamane T, Hagiwara N, Tateishi M, Akachi S, Kim M, et al.: Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn J Cancer Res 82, 1336–1339, 1991.
   PubMedGoogle Scholar
• Xu M, Bailey AC, Hernaez JF, Taoka CR, Schut HA, et al.: Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 17, 1429–1434, 1996.
   PubMed Web of Science ®Google Scholar
• Challa A, Rao DR, and Reddy BS: Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea. Carcinogenesis 18, 2023–2026, 1997.
   PubMed Web of Science ®Google Scholar
• Wargovich MJ, Jimenez A, McKee K, Steele VE, Velasco M, et al.: Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21, 1149–1155, 2000.
   PubMed Web of Science ®Google Scholar
• Hirose M, Hoshiya T, Mizoguchi Y, Nakamura A, Akagi K, et al.: Green tea catechins enhance tumor development in the colon without effects in the lung or thyroid after pretreatment with 1,2-Dimethylhydrazine or 2,2′-dihydroxy-di-n-propylnitrosamine in male F344 rats. Cancer Lett 168, 23–29, 2001.
   PubMed Web of Science ®Google Scholar
• Hirose M, Yamaguchi T, Mizoguchi Y, Akagi K, Futakuchi M, et al.: Lack of inhibitory effects of green tea catechins in 1,2-dimetylhydrazine-induced rat intestinal carcinogenesis model: comparison of the different formulations, administration routes and doses. Cancer Lett 188, 163–170, 2002.
   PubMed Web of Science ®Google Scholar
• Weisburger JH, Rivenson A, Aliaga C, Reinhardt J, Kelloff GJ, et al.: Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer. Proc Soc Exp Biol Med 217, 104–108, 1998.
   PubMed Web of Science ®Google Scholar
• Caderni G, De Filippo C, Luceri C, Salvadori M, Giannini A, et al.: Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 21, 1965–1969, 2000.
   PubMed Web of Science ®Google Scholar
• Xiao H, Hao X, Simi B, Ju J, Jiang H, et al.: Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 29, 113–119, 2008.
   PubMed Web of Science ®Google Scholar
• Rao CV, Hirose Y, Indranie C, and Reddy BS: Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61, 1927–1933, 2001.
   PubMed Web of Science ®Google Scholar
• Hao XP, Pretlow TG, Rao JS, and Pretlow TP: Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 61, 8085–8088, 2001.
   PubMed Web of Science ®Google Scholar
• Hao X, Du M, Bishop AE, and Talbot IC: Imbalance between proliferation and apoptosis in the development of colorectal carcinoma. Virchows Arch 433, 523–527, 1998.
   PubMed Web of Science ®Google Scholar
• Hao X, Tomlinson I, Ilyas M, Palazzo JP, and Talbot IC: Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours. Virchows Arch 431, 167–172, 1997.
   PubMed Web of Science ®Google Scholar
• Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, et al.: Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339, 1277–1284, 1998.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Prabhu S, Meng X, Li C, and Yang CS: An improved method for the determination of green and black tea polyphenols in biomatrices by high-performance liquid chromatography with coulometric array detection. Anal Biochem 279, 164–169, 2000.
   PubMed Web of Science ®Google Scholar
• Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, et al.: Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 187, 295–301, 1999.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Fukuda K, Sugimura T, and Wakabayashi K: Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 58, 42–46, 1998.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Deguchi A, Joe AK, McKoy JF, Moriwaki H, et al.: EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol 5, 69–78, 2005.
   PubMedGoogle Scholar
• Peng G, Dixon DA, Muga SJ, Smith TJ, and Wargovich MJ: Green tea polyphenol (−)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog 45, 309–319, 2006.
   PubMed Web of Science ®Google Scholar
• Kastner P, Grondona JM, Mark M, Gansmuller A, LeMeur M, et al.: Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78, 987–1003, 1994.
   PubMed Web of Science ®Google Scholar
• Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, et al.: RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 8, 1007–1018, 1994.
   PubMed Web of Science ®Google Scholar
• Huang J, Powell WC, Khodavirdi AC, Wu J, Makita T, et al.: Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res 62, 4812–4819, 2002.
   PubMed Web of Science ®Google Scholar
• Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, et al.: Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 61, 4306–4310, 2001.
   PubMed Web of Science ®Google Scholar
• Jiang SY, Shen SR, Shyu RY, Yu JC, Harn HJ, et al.: Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization. Br J Cancer 80, 206–214, 1999.
   PubMed Web of Science ®Google Scholar
• Mao GE, Reuter VE, Cordon-Cardo C, Dalbagni G, Scher HI, et al.: Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. Cancer Epidemiol Biomarkers Prev 13, 383–390, 2004.
   PubMed Web of Science ®Google Scholar
• Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, et al.: Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res 57, 4992–4996, 1997.
   PubMed Web of Science ®Google Scholar
• Giaginis C, Koutsounas I, Alexandrou P, Zizi-Serbetzoglou A, Patsouris E, et al.: Elevated Farnesoid X Receptor (FXR) and Retinoid X Receptors (RXRs) expression is associated with less tumor aggressiveness and favourable prognosis in patients with pancreatic adenocarcinoma. Neoplasma 62, 332–341, 2015.
   PubMed Web of Science ®Google Scholar
• Gauchotte G, Lacomme S, Brochin L, Tournier B, Cahn V, et al.: Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid. Virchows Arch 462, 619–632, 2013.
   PubMed Web of Science ®Google Scholar
• Schneider K, Oltmanns J, and Hassauer M: Allometric principles for interspecies extrapolation in toxicological risk assessment—empirical investigations. Regul Toxicol Pharmacol 39, 334–347, 2004.
   PubMed Web of Science ®Google Scholar